This AI Guessed Tomorrow’s Stock Price Correctly For Amicus Therapeutics And Intuitive Surgical

(VIANEWS) – The Innrs Artificial Intelligence algorithm has been making predictions about the next day stock price and guessing some of them correctly.

We, at Via News, will follow this AI algorithm and publish the results every week day.

Yesterday’s AI prediction for today would produce a ROI of -0.69% if an investor was to invest following yesterday’s Innrs AI suggestion.

See the data in the table below.

Financial Asset Accuracy Prediction ROI
Amicus Therapeutics (FOLD) 88.54% $11.66 4.06% ✅
Intuitive Surgical (ISRG) 87.42% $308.12 1.25% ✅
Hormel Foods (HRL) 88.32% $41.25 0.97% ✅
Kodak (KODK) 84.85% $2.94 0.92% ✅
Biogen (BIIB) 83.77% $314.42 0.6% ✅
America Movil (AMX) 84% $21.6 0.56% ✅
Air Products and Chemicals (APD) 83.93% $302.17 0.38% ✅
Kellogg Company (K) 83.98% $72.48 0.24% ✅
Unilever (UL) 88.23% $56.56 0.23% ✅
Kimberly (KMB) 84.29% $147.6 -0.03%
The Hershey Company (HSY) 83.91% $278.88 -0.09%
Mastercard (MA) 84.01% $380.84 -0.15%
Laboratory Corporation of America Holdings (LH) 88.13% $229.38 -0.21%
General Mills (GIS) 88.3% $91.29 -0.33%
Coca-Cola (KO) 92.9% $65.59 -0.34%
McCormick & Company (MKC) 88.14% $90.14 -0.55%
ConAgra Foods (CAG) 93.47% $38.67 -0.68%
Exelon (EXC) 83.83% $43.69 -0.77%
Electronic Arts (EA) 87.38% $129.34 -0.87%
Fifth Third Bancorp (FITBI) 88.93% $24.88 -0.94%
Smith & Nephew (SNN) 84.03% $32.92 -1.05%
Johnson & Johnson (JNJ) 87.15% $169.74 -1.08%
Tenet Healthcare (THC) 88.95% $71.44 -2.22%
Incyte Corporation (INCY) 88.59% $71.62 -2.9%
Las Vegas Sands Corp (LVS) 83.98% $65.31 -3.68%
Yum! (YUM) 89.27% $144.34 -4.09%
MGM Resorts (MGM) 83.86% $46.81 -4.2%
Uber (UBER) 83.99% $35.58 -4.36%

1. Amicus Therapeutics (FOLD)

Amicus Therapeutics has been having an accuracy rate of 88.54% over the last 10 sessions. Previous close price was $11.59 the AI prediction was $11.66 and today’s closing price was $12.06. The intraday ROI for Amicus Therapeutics (FOLD) was 4.06%.

Shares of Amicus Therapeutics jumped by a staggering 10.06% in from $10.93 to $12.03 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is falling 0.46% to $12,025.33, after three sequential sessions in a row of losses.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases.

Earnings Per Share

As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-0.85.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -109.93%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Amicus Therapeutics’s EBITDA is -61.15.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 50% and 42.9%, respectively.

Sales Growth

Amicus Therapeutics’s sales growth is 6.2% for the present quarter and 11.9% for the next.

More news about Amicus Therapeutics.

2. Intuitive Surgical (ISRG)

Intuitive Surgical has been having an accuracy rate of 87.42% over the last 10 sessions. Previous close price was $301.3 the AI prediction was $308.12 and today’s closing price was $305.06. The intraday ROI for Intuitive Surgical (ISRG) was 1.25%.

Shares of Intuitive Surgical rose by a staggering 19.86% in from $254.43 to $304.96 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is dropping 0.46% to $12,025.33, after three sequential sessions in a row of losses.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

Earnings Per Share

As for profitability, Intuitive Surgical has a trailing twelve months EPS of $3.67.

PE Ratio

Intuitive Surgical has a trailing twelve months price to earnings ratio of 83.1. Meaning, the purchaser of the share is investing $83.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.39%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14%, now sitting on 6.43B for the twelve trailing months.

Volume

Today’s last reported volume for Intuitive Surgical is 1259050 which is 24.19% below its average volume of 1660830.

Moving Average

Intuitive Surgical’s value is way above its 50-day moving average of $252.81 and way above its 200-day moving average of $239.99.

More news about Intuitive Surgical.

3. Hormel Foods (HRL)

Hormel Foods has been having an accuracy rate of 88.32% over the last 10 sessions. Previous close price was $40.24 the AI prediction was $41.25 and today’s closing price was $40.63. The intraday ROI for Hormel Foods (HRL) was 0.97%.

Shares of Hormel Foods slid 0.81% in from $40.94 to $40.61 at 22:29 EST on Wednesday, after two successive sessions in a row of gains. NYSE is dropping 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and food products to retail, foodservice, deli, and commercial customers in the United States and internationally.

Earnings Per Share

As for profitability, Hormel Foods has a trailing twelve months EPS of $1.76.

PE Ratio

Hormel Foods has a trailing twelve months price to earnings ratio of 23.07. Meaning, the purchaser of the share is investing $23.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.

More news about Hormel Foods.

4. Kodak (KODK)

Kodak has been having an accuracy rate of 84.85% over the last 10 sessions. Previous close price was $3.26 the AI prediction was $2.94 and today’s closing price was $3.23. The intraday ROI for Kodak (KODK) was 0.92%.

Shares of Kodak fell by a staggering 23.33% in from $4.3 to $3.30 at 22:29 EST on Wednesday, following the last session’s downward trend. NYSE is falling 0.53% to $15,233.85, after three sequential sessions in a row of losses.

Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide.

Earnings Per Share

As for profitability, Kodak has a trailing twelve months EPS of $0.16.

PE Ratio

Kodak has a trailing twelve months price to earnings ratio of 20.59. Meaning, the purchaser of the share is investing $20.59 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.34%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kodak’s EBITDA is 20.97.

Yearly Top and Bottom Value

Kodak’s stock is valued at $3.30 at 22:29 EST, way under its 52-week high of $7.24 and way above its 52-week low of $2.78.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kodak’s stock is considered to be oversold (<=20).

More news about Kodak.

5. Biogen (BIIB)

Biogen has been having an accuracy rate of 83.77% over the last 10 sessions. Previous close price was $309.13 the AI prediction was $314.42 and today’s closing price was $311. The intraday ROI for Biogen (BIIB) was 0.6%.

Shares of Biogen jumped by a staggering 13.12% in from $275.02 to $311.10 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is sliding 0.46% to $12,025.33, after three sequential sessions in a row of losses.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Earnings Per Share

As for profitability, Biogen has a trailing twelve months EPS of $21.96.

PE Ratio

Biogen has a trailing twelve months price to earnings ratio of 14.17. Meaning, the purchaser of the share is investing $14.17 for every dollar of annual earnings.

Volume

Today’s last reported volume for Biogen is 2425340 which is 166.11% above its average volume of 911380.

Moving Average

Biogen’s value is way higher than its 50-day moving average of $275.75 and way higher than its 200-day moving average of $261.49.

More news about Biogen.

6. America Movil (AMX)

America Movil has been having an accuracy rate of 84% over the last 10 sessions. Previous close price was $21.34 the AI prediction was $21.6 and today’s closing price was $21.46. The intraday ROI for America Movil (AMX) was 0.56%.

Shares of America Movil jumped 1.41% in from $21.3 to $21.60 at 22:29 EST on Wednesday, after two sequential sessions in a row of gains. NYSE is sliding 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally.

Earnings Per Share

As for profitability, America Movil has a trailing twelve months EPS of $1.43.

PE Ratio

America Movil has a trailing twelve months price to earnings ratio of 15.1. Meaning, the purchaser of the share is investing $15.1 for every dollar of annual earnings.

Volatility

America Movil’s last week, last month’s, and last quarter’s current intraday variation average was 0.29%, 0.04%, and 0.99%.

America Movil’s highest amplitude of average volatility was 0.47% (last week), 0.82% (last month), and 0.99% (last quarter).

Sales Growth

America Movil’s sales growth is 7.5% for the present quarter and 10.9% for the next.

More news about America Movil.

7. Air Products and Chemicals (APD)

Air Products and Chemicals has been having an accuracy rate of 83.93% over the last 10 sessions. Previous close price was $292.79 the AI prediction was $302.17 and today’s closing price was $293.89. The intraday ROI for Air Products and Chemicals (APD) was 0.38%.

Shares of Air Products and Chemicals jumped 3.27% in from $284.9 to $294.22 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is dropping 0.53% to $15,233.85, after three successive sessions in a row of losses.

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally.

Earnings Per Share

As for profitability, Air Products and Chemicals has a trailing twelve months EPS of $10.01.

PE Ratio

Air Products and Chemicals has a trailing twelve months price to earnings ratio of 29.39. Meaning, the purchaser of the share is investing $29.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.84%.

More news about Air Products and Chemicals.

8. Kellogg Company (K)

Kellogg Company has been having an accuracy rate of 83.98% over the last 10 sessions. Previous close price was $71.36 the AI prediction was $72.48 and today’s closing price was $71.53. The intraday ROI for Kellogg Company (K) was 0.24%.

Shares of Kellogg Company rose 6.43% in from $67.29 to $71.62 at 22:29 EST on Wednesday, after five sequential sessions in a row of gains. NYSE is sliding 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Kellogg Company, together with its subsidiaries, manufactures and markets snacks and convenience foods.

Earnings Per Share

As for profitability, Kellogg Company has a trailing twelve months EPS of $2.79.

PE Ratio

Kellogg Company has a trailing twelve months price to earnings ratio of 25.67. Meaning, the purchaser of the share is investing $25.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kellogg Company’s EBITDA is -427.61.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 10% and a negative 6.8%, respectively.

Moving Average

Kellogg Company’s value is above its 50-day moving average of $66.56 and above its 200-day moving average of $70.81.

Volume

Today’s last reported volume for Kellogg Company is 3133600 which is 49.6% above its average volume of 2094560.

More news about Kellogg Company.

9. Unilever (UL)

Unilever has been having an accuracy rate of 88.23% over the last 10 sessions. Previous close price was $55.36 the AI prediction was $56.56 and today’s closing price was $55.49. The intraday ROI for Unilever (UL) was 0.23%.

Shares of Unilever rose 5.06% in from $52.92 to $55.60 at 22:29 EST on Wednesday, after three consecutive sessions in a row of gains. NYSE is falling 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Unilever PLC operates as a fast-moving consumer goods company.

Earnings Per Share

As for profitability, Unilever has a trailing twelve months EPS of $3.33.

PE Ratio

Unilever has a trailing twelve months price to earnings ratio of 16.7. Meaning, the purchaser of the share is investing $16.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.9%.

Volume

Today’s last reported volume for Unilever is 903450 which is 54.07% below its average volume of 1967400.

Moving Average

Unilever’s value is higher than its 50-day moving average of $51.72 and way higher than its 200-day moving average of $48.79.

Yearly Top and Bottom Value

Unilever’s stock is valued at $55.60 at 22:29 EST, under its 52-week high of $55.99 and way higher than its 52-week low of $42.44.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 1.78 and the estimated forward annual dividend yield is 3.21%.

More news about Unilever.

10. Kimberly (KMB)

Kimberly has been having an accuracy rate of 84.29% over the last 10 sessions. Previous close price was $145.62 the AI prediction was $147.6 and today’s closing price was $145.58. The intraday ROI for Kimberly (KMB) was -0.03%.

Shares of Kimberly jumped 9.32% in from $134.2 to $146.71 at 22:29 EST on Wednesday, following the last session’s downward trend. NYSE is falling 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide.

Earnings Per Share

As for profitability, Kimberly has a trailing twelve months EPS of $5.84.

PE Ratio

Kimberly has a trailing twelve months price to earnings ratio of 25.12. Meaning, the purchaser of the share is investing $25.12 for every dollar of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kimberly’s stock is considered to be oversold (<=20).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 4.72 and the estimated forward annual dividend yield is 3.29%.

Volatility

Kimberly’s last week, last month’s, and last quarter’s current intraday variation average was 0.20%, 0.43%, and 0.78%.

Kimberly’s highest amplitude of average volatility was 0.56% (last week), 0.69% (last month), and 0.78% (last quarter).

More news about Kimberly.

11. The Hershey Company (HSY)

The Hershey Company has been having an accuracy rate of 83.91% over the last 10 sessions. Previous close price was $274.47 the AI prediction was $278.88 and today’s closing price was $274.21. The intraday ROI for The Hershey Company (HSY) was -0.09%.

Shares of The Hershey Company jumped 6.05% in from $258.03 to $273.64 at 22:29 EST on Wednesday, after four consecutive sessions in a row of losses. NYSE is falling 0.53% to $15,233.85, after three sequential sessions in a row of losses.

The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally.

Earnings Per Share

As for profitability, The Hershey Company has a trailing twelve months EPS of $8.23.

PE Ratio

The Hershey Company has a trailing twelve months price to earnings ratio of 33.25. Meaning, the purchaser of the share is investing $33.25 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.31%.

Volatility

The Hershey Company’s last week, last month’s, and last quarter’s current intraday variation average was 0.10%, 0.32%, and 0.70%.

The Hershey Company’s highest amplitude of average volatility was 0.59% (last week), 0.70% (last month), and 0.70% (last quarter).

More news about The Hershey Company.

12. Mastercard (MA)

Mastercard has been having an accuracy rate of 84.01% over the last 10 sessions. Previous close price was $375.45 the AI prediction was $380.84 and today’s closing price was $374.9. The intraday ROI for Mastercard (MA) was -0.15%.

Shares of Mastercard rose 3.73% in from $364.18 to $377.76 at 22:29 EST on Wednesday, after five sequential sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after three sequential sessions in a row of losses.

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally.

Earnings Per Share

As for profitability, Mastercard has a trailing twelve months EPS of $9.93.

PE Ratio

Mastercard has a trailing twelve months price to earnings ratio of 38.04. Meaning, the purchaser of the share is investing $38.04 for every dollar of annual earnings.

Volatility

Mastercard’s last week, last month’s, and last quarter’s current intraday variation average was 0.03%, 0.09%, and 0.77%.

Mastercard’s highest amplitude of average volatility was 0.45% (last week), 0.61% (last month), and 0.77% (last quarter).

Moving Average

Mastercard’s value is above its 50-day moving average of $360.56 and above its 200-day moving average of $344.56.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Mastercard’s stock is considered to be overbought (>=80).

More news about Mastercard.

13. Laboratory Corporation of America Holdings (LH)

Laboratory Corporation of America Holdings has been having an accuracy rate of 88.13% over the last 10 sessions. Previous close price was $226.47 the AI prediction was $229.38 and today’s closing price was $225.99. The intraday ROI for Laboratory Corporation of America Holdings (LH) was -0.21%.

Shares of Laboratory Corporation of America Holdings dropped 2.15% in from $231 to $226.03 at 22:29 EST on Wednesday, after two sequential sessions in a row of gains. NYSE is sliding 0.53% to $15,233.85, after three successive sessions in a row of losses.

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.

Earnings Per Share

As for profitability, Laboratory Corporation of America Holdings has a trailing twelve months EPS of $11.14.

PE Ratio

Laboratory Corporation of America Holdings has a trailing twelve months price to earnings ratio of 20.29. Meaning, the purchaser of the share is investing $20.29 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.55%.

Yearly Top and Bottom Value

Laboratory Corporation of America Holdings’s stock is valued at $226.03 at 22:29 EST, way under its 52-week high of $280.72 and way higher than its 52-week low of $200.32.

More news about Laboratory Corporation of America Holdings.

14. General Mills (GIS)

General Mills has been having an accuracy rate of 88.3% over the last 10 sessions. Previous close price was $89.12 the AI prediction was $91.29 and today’s closing price was $88.83. The intraday ROI for General Mills (GIS) was -0.33%.

Shares of General Mills jumped 3.13% in from $86.07 to $88.76 at 22:29 EST on Wednesday, after four sequential sessions in a row of losses. NYSE is sliding 0.53% to $15,233.85, after three successive sessions in a row of losses.

General Mills, Inc. manufactures and markets branded consumer foods worldwide.

Earnings Per Share

As for profitability, General Mills has a trailing twelve months EPS of $4.61.

PE Ratio

General Mills has a trailing twelve months price to earnings ratio of 19.25. Meaning, the purchaser of the share is investing $19.25 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.39%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 5.4% and positive 1.8% for the next.

Moving Average

General Mills’s worth is higher than its 50-day moving average of $80.78 and way above its 200-day moving average of $79.45.

More news about General Mills.

15. Coca-Cola (KO)

Coca-Cola has been having an accuracy rate of 92.9% over the last 10 sessions. Previous close price was $63.87 the AI prediction was $65.59 and today’s closing price was $63.65. The intraday ROI for Coca-Cola (KO) was -0.34%.

Shares of Coca-Cola jumped 2.98% in from $62.15 to $64.00 at 22:29 EST on Wednesday, after two successive sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after three successive sessions in a row of losses.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide.

Earnings Per Share

As for profitability, Coca-Cola has a trailing twelve months EPS of $2.26.

PE Ratio

Coca-Cola has a trailing twelve months price to earnings ratio of 28.32. Meaning, the purchaser of the share is investing $28.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.83%.

More news about Coca-Cola.

16. McCormick & Company (MKC)

McCormick & Company has been having an accuracy rate of 88.14% over the last 10 sessions. Previous close price was $88.41 the AI prediction was $90.14 and today’s closing price was $87.92. The intraday ROI for McCormick & Company (MKC) was -0.55%.

Shares of McCormick & Company jumped 3.32% in from $85.27 to $88.10 at 22:29 EST on Wednesday, after four consecutive sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after three sequential sessions in a row of losses.

McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry.

Earnings Per Share

As for profitability, McCormick & Company has a trailing twelve months EPS of $2.47.

PE Ratio

McCormick & Company has a trailing twelve months price to earnings ratio of 35.67. Meaning, the purchaser of the share is investing $35.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.02%.

Yearly Top and Bottom Value

McCormick & Company’s stock is valued at $88.10 at 22:29 EST, way under its 52-week high of $105.19 and way above its 52-week low of $70.60.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 5, 2023, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 1.84%.

More news about McCormick & Company.

17. ConAgra Foods (CAG)

ConAgra Foods has been having an accuracy rate of 93.47% over the last 10 sessions. Previous close price was $38.35 the AI prediction was $38.67 and today’s closing price was $38.09. The intraday ROI for ConAgra Foods (CAG) was -0.68%.

Shares of ConAgra Foods jumped 2.23% in from $37.65 to $38.49 at 22:29 EST on Wednesday, following the last session’s downward trend. NYSE is falling 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company in North America.

Earnings Per Share

As for profitability, ConAgra Foods has a trailing twelve months EPS of $1.67.

PE Ratio

ConAgra Foods has a trailing twelve months price to earnings ratio of 23.05. Meaning, the purchaser of the share is investing $23.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.05%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 6.2% and positive 10.5% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 12.21B for the twelve trailing months.

Volatility

ConAgra Foods’s last week, last month’s, and last quarter’s current intraday variation average was 0.23%, 0.09%, and 0.79%.

ConAgra Foods’s highest amplitude of average volatility was 0.61% (last week), 0.73% (last month), and 0.79% (last quarter).

More news about ConAgra Foods.

18. Exelon (EXC)

Exelon has been having an accuracy rate of 83.83% over the last 10 sessions. Previous close price was $42.66 the AI prediction was $43.69 and today’s closing price was $42.33. The intraday ROI for Exelon (EXC) was -0.77%.

Shares of Exelon rose 1.94% in from $41.83 to $42.64 at 22:29 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ is sliding 0.46% to $12,025.33, after three consecutive sessions in a row of losses.

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada.

Earnings Per Share

As for profitability, Exelon has a trailing twelve months EPS of $2.08.

PE Ratio

Exelon has a trailing twelve months price to earnings ratio of 20.5. Meaning, the purchaser of the share is investing $20.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.9%.

Volatility

Exelon’s last week, last month’s, and last quarter’s current intraday variation average was 0.14%, 0.14%, and 1.16%.

Exelon’s highest amplitude of average volatility was 1.26% (last week), 0.89% (last month), and 1.16% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Exelon’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Exelon’s stock is valued at $42.64 at 22:29 EST, way under its 52-week high of $49.86 and way higher than its 52-week low of $35.19.

More news about Exelon.

19. Electronic Arts (EA)

Electronic Arts has been having an accuracy rate of 87.38% over the last 10 sessions. Previous close price was $126.17 the AI prediction was $129.34 and today’s closing price was $125.07. The intraday ROI for Electronic Arts (EA) was -0.87%.

Shares of Electronic Arts dropped 0.1% in from $125.17 to $125.04 at 22:29 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ is dropping 0.46% to $12,025.33, after three consecutive sessions in a row of losses.

Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide.

Earnings Per Share

As for profitability, Electronic Arts has a trailing twelve months EPS of $3.71.

PE Ratio

Electronic Arts has a trailing twelve months price to earnings ratio of 33.7. Meaning, the purchaser of the share is investing $33.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.7%.

More news about Electronic Arts.

20. Fifth Third Bancorp (FITBI)

Fifth Third Bancorp has been having an accuracy rate of 88.93% over the last 10 sessions. Previous close price was $24.55 the AI prediction was $24.88 and today’s closing price was $24.32. The intraday ROI for Fifth Third Bancorp (FITBI) was -0.94%.

Shares of Fifth Third Bancorp rose 5.27% in from $23.16 to $24.38 at 22:29 EST on Wednesday, after two consecutive sessions in a row of losses. NASDAQ is sliding 0.46% to $12,025.33, after three successive sessions in a row of losses.

Fifth Third Bancorp operates as a diversified financial services company in the United States.

Earnings Per Share

As for profitability, Fifth Third Bancorp has a trailing twelve months EPS of $3.48.

PE Ratio

Fifth Third Bancorp has a trailing twelve months price to earnings ratio of 7. Meaning, the purchaser of the share is investing $7 for every dollar of annual earnings.

Yearly Top and Bottom Value

Fifth Third Bancorp’s stock is valued at $24.38 at 22:29 EST, below its 52-week high of $27.06 and way above its 52-week low of $21.08.

Volume

Today’s last reported volume for Fifth Third Bancorp is 74630 which is 14.08% below its average volume of 86865.

Volatility

Fifth Third Bancorp’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.12%, a positive 0.26%, and a positive 1.32%.

Fifth Third Bancorp’s highest amplitude of average volatility was 0.39% (last week), 0.72% (last month), and 1.32% (last quarter).

More news about Fifth Third Bancorp.

21. Smith & Nephew (SNN)

Smith & Nephew has been having an accuracy rate of 84.03% over the last 10 sessions. Previous close price was $32.47 the AI prediction was $32.92 and today’s closing price was $32.13. The intraday ROI for Smith & Nephew (SNN) was -1.05%.

Shares of Smith & Nephew rose by a staggering 14.02% in from $28.17 to $32.12 at 22:29 EST on Wednesday, after five consecutive sessions in a row of losses. NYSE is falling 0.53% to $15,233.85, after three sequential sessions in a row of losses.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.

Earnings Per Share

As for profitability, Smith & Nephew has a trailing twelve months EPS of $0.51.

PE Ratio

Smith & Nephew has a trailing twelve months price to earnings ratio of 62.99. Meaning, the purchaser of the share is investing $62.99 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.12%.

Volume

Today’s last reported volume for Smith & Nephew is 897861 which is 2% below its average volume of 916266.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.5%.

Yearly Top and Bottom Value

Smith & Nephew’s stock is valued at $32.12 at 22:29 EST, below its 52-week high of $34.12 and way above its 52-week low of $21.78.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Smith & Nephew’s stock is considered to be overbought (>=80).

More news about Smith & Nephew.

22. Johnson & Johnson (JNJ)

Johnson & Johnson has been having an accuracy rate of 87.15% over the last 10 sessions. Previous close price was $164.64 the AI prediction was $169.74 and today’s closing price was $162.87. The intraday ROI for Johnson & Johnson (JNJ) was -1.08%.

Shares of Johnson & Johnson jumped 3.69% in from $158.54 to $164.39 at 22:29 EST on Wednesday, following the last session’s downward trend. NYSE is sliding 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide.

Earnings Per Share

As for profitability, Johnson & Johnson has a trailing twelve months EPS of $4.78.

PE Ratio

Johnson & Johnson has a trailing twelve months price to earnings ratio of 34.39. Meaning, the purchaser of the share is investing $34.39 for every dollar of annual earnings.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 1.2% and 6.7%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Johnson & Johnson’s EBITDA is 5.45.

Yearly Top and Bottom Value

Johnson & Johnson’s stock is valued at $164.39 at 22:29 EST, way under its 52-week high of $183.35 and above its 52-week low of $150.11.

More news about Johnson & Johnson.

23. Tenet Healthcare (THC)

Tenet Healthcare has been having an accuracy rate of 88.95% over the last 10 sessions. Previous close price was $70.26 the AI prediction was $71.44 and today’s closing price was $68.7. The intraday ROI for Tenet Healthcare (THC) was -2.22%.

Shares of Tenet Healthcare rose by a staggering 19.66% in from $58.43 to $69.92 at 22:29 EST on Wednesday, after five sequential sessions in a row of losses. NYSE is falling 0.53% to $15,233.85, after three sequential sessions in a row of losses.

Tenet Healthcare Corporation operates as a diversified healthcare services company.

Earnings Per Share

As for profitability, Tenet Healthcare has a trailing twelve months EPS of $3.77.

PE Ratio

Tenet Healthcare has a trailing twelve months price to earnings ratio of 18.55. Meaning, the purchaser of the share is investing $18.55 for every dollar of annual earnings.

More news about Tenet Healthcare.

24. Incyte Corporation (INCY)

Incyte Corporation has been having an accuracy rate of 88.59% over the last 10 sessions. Previous close price was $70.07 the AI prediction was $71.62 and today’s closing price was $68.04. The intraday ROI for Incyte Corporation (INCY) was -2.9%.

Shares of Incyte Corporation fell 5.63% in from $72.79 to $68.69 at 22:29 EST on Wednesday, after two sequential sessions in a row of losses. NASDAQ is dropping 0.46% to $12,025.33, after three sequential sessions in a row of losses.

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally.

Earnings Per Share

As for profitability, Incyte Corporation has a trailing twelve months EPS of $1.54.

PE Ratio

Incyte Corporation has a trailing twelve months price to earnings ratio of 44.6. Meaning, the purchaser of the share is investing $44.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.37%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Incyte Corporation’s EBITDA is 183.73.

Volatility

Incyte Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.06%, a negative 0.34%, and a positive 1.27%.

Incyte Corporation’s highest amplitude of average volatility was 3.20% (last week), 1.46% (last month), and 1.27% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Incyte Corporation’s stock is considered to be overbought (>=80).

More news about Incyte Corporation.

25. Las Vegas Sands Corp (LVS)

Las Vegas Sands Corp has been having an accuracy rate of 83.98% over the last 10 sessions. Previous close price was $63.78 the AI prediction was $65.31 and today’s closing price was $61.43. The intraday ROI for Las Vegas Sands Corp (LVS) was -3.68%.

Shares of Las Vegas Sands Corp jumped 8.46% in from $57.65 to $62.53 at 22:29 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is falling 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Macao and Singapore.

Earnings Per Share

As for profitability, Las Vegas Sands Corp has a trailing twelve months EPS of $-0.72.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.58%.

Yearly Top and Bottom Value

Las Vegas Sands Corp’s stock is valued at $62.53 at 22:29 EST, below its 52-week high of $64.04 and way above its 52-week low of $28.88.

Moving Average

Las Vegas Sands Corp’s worth is above its 50-day moving average of $57.55 and way higher than its 200-day moving average of $46.93.

More news about Las Vegas Sands Corp.

26. Yum! (YUM)

Yum! has been having an accuracy rate of 89.27% over the last 10 sessions. Previous close price was $143.16 the AI prediction was $144.34 and today’s closing price was $137.31. The intraday ROI for Yum! (YUM) was -4.09%.

Shares of Yum! rose 4.5% in from $131.42 to $137.33 at 22:29 EST on Wednesday, after two successive sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after three consecutive sessions in a row of losses.

Yum!

Earnings Per Share

As for profitability, Yum! has a trailing twelve months EPS of $4.59.

PE Ratio

Yum! has a trailing twelve months price to earnings ratio of 29.92. Meaning, the purchaser of the share is investing $29.92 for every dollar of annual earnings.

Volatility

Yum!’s last week, last month’s, and last quarter’s current intraday variation average was 0.05%, 0.36%, and 0.77%.

Yum!’s highest amplitude of average volatility was 1.21% (last week), 0.72% (last month), and 0.77% (last quarter).

More news about Yum!.

27. MGM Resorts (MGM)

MGM Resorts has been having an accuracy rate of 83.86% over the last 10 sessions. Previous close price was $45.66 the AI prediction was $46.81 and today’s closing price was $43.74. The intraday ROI for MGM Resorts (MGM) was -4.2%.

Shares of MGM Resorts jumped 1.73% in from $43.92 to $44.68 at 22:29 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is sliding 0.53% to $15,233.85, after three sequential sessions in a row of losses.

MGM Resorts International, through its subsidiaries, owns and operates casino, hotel, and entertainment resorts in the United States and Macau.

Earnings Per Share

As for profitability, MGM Resorts has a trailing twelve months EPS of $4.79.

PE Ratio

MGM Resorts has a trailing twelve months price to earnings ratio of 9.33. Meaning, the purchaser of the share is investing $9.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.51%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MGM Resorts’s EBITDA is 27.08.

More news about MGM Resorts.

28. Uber (UBER)

Uber has been having an accuracy rate of 83.99% over the last 10 sessions. Previous close price was $36.26 the AI prediction was $35.58 and today’s closing price was $37.84. The intraday ROI for Uber (UBER) was -4.36%.

Shares of Uber rose by a staggering 20.57% in from $31.41 to $37.87 at 22:29 EST on Wednesday, after five successive sessions in a row of gains. NYSE is sliding 0.53% to $15,233.85, after three sequential sessions in a row of losses.

Uber Technologies, Inc. develops and operates proprietary technology applications in the United States, Canada, Latin America, Europe, the Middle East, Africa, and Asia excluding China and Southeast Asia.

Earnings Per Share

As for profitability, Uber has a trailing twelve months EPS of $-5.72.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.62%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 49%, now sitting on 31.88B for the twelve trailing months.

Moving Average

Uber’s worth is way higher than its 50-day moving average of $32.08 and way higher than its 200-day moving average of $29.37.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Uber’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 97% and 96.2%, respectively.

Previous days news about Uber

  • Here's what key metrics tell us about Uber (Uber) Q1 earnings. According to Zacks on Tuesday, 2 May, "For the quarter ended March 2023, Uber Technologies (UBER Quick QuoteUBER – Free Report) reported revenue of $8.82 billion, up 28.7% over the same period last year. ", "Here is how Uber performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
  • According to Zacks on Tuesday, 2 May, "Revenues of $8.82 billion outperformed the Zacks consensus by +1.44%, and well ahead of the $6.85 billion in Q1 of 2022, when the company was much more reliant on Uber Eats food delivery service. "
  • According to Zacks on Wednesday, 3 May, "Uber Technologies, Inc. price-consensus-eps-surprise-chart | Uber Technologies, Inc. Quote", "For the second quarter of 2023, Uber expects gross bookings of $33 billion-$34 billion. "

More news about Uber.

Leave a Reply

Your email address will not be published. Required fields are marked *